Levodopa‐induced dyskinesias and continuous subcutaneous infusions of apomorphine: Results of a two‐year, prospective follow‐up

Twelve patients with levodopa‐induced dyskinesias were treated with continuous subcutaneous apomorphine. A markedly significant reduction in peak dose dyskinesias occurred over a two‐year follow‐up. © 2001 Movement Disorder Society

[1]  D. Aberfeld.  Disappearing palatal myoclonus , 1982, Neurology.

[2]  D. Margouleff,et al.  Positron emission tomographic findings in Filipino X‐linked dystonia–parkinsonism , 1993, Annals of neurology.

[3]  M. Al‐Hakim,et al.  Parkinson's Disease and Movement Disorders, 2nd Ed. , 1994, Neurology.

[4]  N. Risch,et al.  The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein , 1997, Nature Genetics.

[5]  M. Youdim,et al.  Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction. , 1996, European journal of pharmacology.

[6]  Klaus Mewes,et al.  Neuronal activity in the basal ganglia in patients with generalized dystonia and hemiballismus , 1999, Annals of neurology.

[7]  C. Marsden,et al.  The role of DYT1 in primary torsion dystonia in Europe. , 1998, Brain : a journal of neurology.

[8]  Neuro-ophthalmic abnormalities in Tourette's syndrome: functional and anatomic implications. , 1984, Neurology.

[9]  C Bolger,et al.  Ocular microtremor in patients with idiopathic Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[10]  N H Holford,et al.  The response to levodopa in parkinson's disease: Imposing pharmacological law and order , 1996, Annals of neurology.

[11]  G. Brookes,et al.  Management of middle ear myoclonus , 1994, The Journal of Laryngology & Otology.

[12]  M. Deschenes,et al.  The thalamus as a neuronal oscillator , 1984, Brain Research Reviews.

[13]  M. Davis,et al.  A primary acoustic startle circuit: lesion and stimulation studies , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[14]  R. Tasker,et al.  Stereotactic thalamotomy for dystonic patients. , 1993, Stereotactic and functional neurosurgery.

[15]  J. Rothwell,et al.  Changes in the balance between motor cortical excitation and inhibition in focal, task specific dystonia. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[16]  C. Marsden,et al.  The clinical use of apomorphine in Parkinson's disease , 1992, Journal of Neurology.

[17]  P. Thompson,et al.  The hyperekplexias and their relationship to the normal startle reflex. , 1991, Brain : a journal of neurology.

[18]  E. Tolosa,et al.  MK-801 prevents levodopa-induced motor response alterations in parkinsonian rats , 1996, Brain Research.

[19]  G K Wenning,et al.  Apomorphine: An underutilized therapy for Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.

[20]  T. Chase,et al.  Levodopa‐induced dyskinesias improved by a glutamate antagonist in parkinsonia monkeys , 1996 .

[21]  L. Metman,et al.  Acute pharmacologic blockade of dyskinesias in Parkinson's disease , 1996, Movement disorders : official journal of the Movement Disorder Society.

[22]  A. Albanese,et al.  Clinical usefulness of apomorphine in movement disorders. , 1994, Clinical neuropharmacology.

[23]  F. Jiménez-Jiménez,et al.  Parkinsonism Associated With Calcium Channel Blockers: A Prospective Follow‐up Study , 1992, Clinical neuropharmacology.

[24]  Paul W. Frankland,et al.  The acoustic startle reflex: neurons and connections , 1995, Brain Research Reviews.

[25]  R. Djaldetti,et al.  Riluzole for le vodopa-induced dyskinesias in advanced P arkinson's disease , 1999, The Lancet.

[26]  M. Brin,et al.  Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. , 1999, Neurology.

[27]  C. Marsden,et al.  The stiff man and stiff man plus syndromes , 1999, Journal of Neurology.

[28]  S Fahn,et al.  The spectrum of levodopa-induced dyskinesias. , 2000, Annals of neurology.

[29]  T. Sanchez,et al.  Continuous, High-frequency Objective Tinnitus Caused by Middle Ear Myoclonus , 1998, Ear, nose, & throat journal.

[30]  L. Grégoire,et al.  Risk Factors for Peak Dose Dyskinesia in 100 Levodopa-treated Parkinsonian Patients , 1996, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[31]  N. Risch,et al.  De novo mutations (GAG deletion) in the DYT1 gene in two non-Jewish patients with early-onset dystonia. , 1998, Human molecular genetics.

[32]  Y Agid,et al.  Is the mesocortical dopaminergic system involved in Parkinson disease? , 1980, Neurology.

[33]  C. Marsden,et al.  Note on the scoliosis of Parkinsonism. , 1975, Journal of neurology, neurosurgery, and psychiatry.

[34]  M. Mintz,et al.  Bilateral imbalance in striatal DA-uptake controls rotation behavior , 1994, Brain Research.

[35]  E. Gatto,et al.  Focal myoclonus associated with posterior thalamic hematoma , 1998, Movement disorders : official journal of the Movement Disorder Society.

[36]  J. Masdeu,et al.  Thalamic astasia: Inability to stand after unilateral thalamic lesions , 1988, Annals of neurology.

[37]  L. Kempe.  Handbook of Physiology. Section I. The Nervous System , 1982 .

[38]  H. Künzle.  Bilateral projections from precentral motor cortex to the putamen and other parts of the basal ganglia. An autoradiographic study inMacaca fascicularis , 1975, Brain Research.

[39]  Alfredo Berardelli,et al.  Pathophysiology of chorea and bradykinesia in Huntington's disease , 1999, Movement disorders : official journal of the Movement Disorder Society.

[40]  Ear clicks in palatal tremor caused by activity of the levator veli palatini , 1996, Neurology.

[41]  S. Rapcsak,et al.  Falling and postural deficits due to acute unilateral basal ganglia lesions. , 1989, Archives of neurology.

[42]  S. Durrleman,et al.  A confirmatory dose-ranging study of riluzole in ALS , 1996, Neurology.

[43]  S. Kish,et al.  Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.

[44]  P. Thompson,et al.  Symptomatic hyperekplexia occurring as a result of pontine infarction , 1997, Movement disorders : official journal of the Movement Disorder Society.

[45]  W. Weiner,et al.  Levodopa‐Induced dopamine receptor hypersensitivity , 1977, Transactions of the American Neurological Association.

[46]  Y. Agid,et al.  DYT1 mutation in French families with idiopathic torsion dystonia. , 1999, Brain : a journal of neurology.

[47]  L. Henderson,et al.  Abnormalities of nonvisually-guided eye movements in Parkinson's disease. , 1989, Brain : a journal of neurology.

[48]  H. Bjork.  Objective tinnitus due to clonus of the soft palate. , 1954, Acta oto-laryngologica. Supplementum.

[49]  W. Poewe,et al.  Kava and dopamine antagonism. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[50]  J. Siegel,et al.  Anatomical distribution and response patterns of reticular neurons active in relation to acoustic startle , 1988, Brain Research.

[51]  S. Mandel,et al.  Apomorphine protects against MPTP‐induced neurotoxicity in mice , 1999, Movement disorders : official journal of the Movement Disorder Society.

[52]  J G Nutt,et al.  Levodopa‐induced dyskinesia , 1990, Neurology.

[53]  G. Deuschl,et al.  Ear click in palatal tremor , 1991, Neurology.

[54]  Mahoney Fi,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 1965 .

[55]  A. Sismanis.  Pulsatile tinnitus. A 15-year experience. , 1998, The American journal of otology.

[56]  Gupta Op,et al.  Velo-pharyngo-laryngeal myoclonia with objective tinnitus. , 1972 .

[57]  A. Korczyn,et al.  Complex segregation analysis of dystonia pedigrees suggests autosomal dominant inheritance , 1990, Neurology.

[58]  H. Shibasaki,et al.  Palatopharyngolaryngeal myokymia resembling "palatal myoclonus". , 1993, Journal of neurology, neurosurgery, and psychiatry.

[59]  A J Lees,et al.  Dopamine agonists in Parkinson's disease: a look at apomorphine , 1993, Fundamental & clinical pharmacology.

[60]  B. Day,et al.  Modulation of postural tremors at the wrist by supramaximal electrical median nerve shocks in essential tremor, Parkinson's disease and normal subjects mimicking tremor. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[61]  M. Hallett,et al.  Reticular reflex myoclonus: a physiological type of human post-hypoxic myoclonus. , 1977, Journal of neurology, neurosurgery, and psychiatry.

[62]  S. Konitsiotis,et al.  Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys. , 1999, The Journal of pharmacology and experimental therapeutics.

[63]  J. Ono,et al.  Characteristic MR features of encephalitis caused by Epstein-Barr virus: a case report , 1998, Pediatric Radiology.

[64]  A. Lang,et al.  Coexistence of tics and parkinsonism: Evidence for non-dopaminergic mechanisms in tic pathogenesis , 1997, Neurology.

[65]  J. Pepping.  Kava: Piper methysticum. , 1999, American Journal of Health-System Pharmacy.

[66]  E. Ernst,et al.  Efficacy of kava extract for treating anxiety: systematic review and meta-analysis. , 2000, Journal of clinical psychopharmacology.

[67]  C. Sabatti,et al.  The DYT1 phenotype and guidelines for diagnostic testing , 2000, Neurology.

[68]  S. Kim,et al.  Pseudochoreoathetosis in four patients with hypesthetic ataxic hemiparesis in a thalamic lesion , 1999, Journal of Neurology.

[69]  P. Vieregge,et al.  Voluntary palatal tremor in two siblings , 1998, Movement disorders : official journal of the Movement Disorder Society.

[70]  T. Engber,et al.  Contribution of dopaminergic and glutamatergic mechanisms to the pathogenesis of motor response complications in Parkinson's disease. , 1996, Advances in neurology.

[71]  M. Horstink,et al.  Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[72]  D. Jamieson,et al.  Kava pyrones and resin: studies on GABAA, GABAB and benzodiazepine binding sites in rodent brain. , 1992, Pharmacology & toxicology.

[73]  J. Dejerine.  Le syndrome thalamique , 1906 .

[74]  M. Sperling,et al.  Epileptic palatal myoclonus , 1991, Neurology.

[75]  J. Bogousslavsky,et al.  Delayed Unilateral Akathisia with Posterior Thalamic Infarct , 1995 .

[76]  D. D. Di Monte,et al.  Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model , 2000, Movement disorders : official journal of the Movement Disorder Society.

[77]  J. Liepert,et al.  Motor cortex disinhibition in acute stroke , 2000, Clinical Neurophysiology.

[78]  Y. Agid,et al.  Frequency of the DYT1 mutation in primary torsion dystonia without family history. , 2000, Archives of neurology.

[79]  L. Metman,et al.  Pathophysiology of motor response complications in Parkinson's disease: Hypotheses on the why, where, and what , 2000, Movement disorders : official journal of the Movement Disorder Society.

[80]  H. Rommelspacher,et al.  Effect of kava extract and individual kavapyrones on neurotransmitter levels in the nucleus accumbens of rats , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[81]  鯨井 隆.  Corticocortical inhibition in human motor cortex , 1994 .

[82]  A. Lees,et al.  Subcutaneous apomorphine in the treatment of Parkinson's disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[83]  T. Engber,et al.  NMDA receptor blockade reverses motor response alterations induced by levodopa. , 1994, Neuroreport.

[84]  M. Youdim,et al.  Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6‐Hydroxydopamine , 1998, Movement disorders : official journal of the Movement Disorder Society.

[85]  Giovanni Puccetti,et al.  “Rubral” tremor after thalamic haemorrhage , 1993, Journal of Neurology.

[86]  J. Bogousslavsky,et al.  The syndrome of posterior choroidal artery territory ifarction , 1996, Annals of neurology.

[87]  Y. Agid,et al.  Eye movements in parkinsonian syndromes , 1994, Annals of neurology.

[88]  J. Vitek.  Surgery for dystonia. , 1998, Neurosurgery clinics of North America.

[89]  M. Yahr,et al.  Ocular dyskinesias in patients with Parkinson's disease treated with levodopa , 1977, Annals of neurology.

[90]  T. Drew,et al.  Corticoreticular pathways in the cat. I. Projection patterns and collaterization. , 1998, Journal of neurophysiology.

[91]  J C Rothwell,et al.  New observations on the normal auditory startle reflex in man. , 1991, Brain : a journal of neurology.

[92]  Schwab Rs,et al.  Apomorphine in Parkinson's disease. , 1951 .

[93]  R. Wurtman,et al.  Nonaminergic striatal neurons convert exogenous l‐dopa to dopamine in parkinsonism , 1980, Annals of neurology.

[94]  J. Obeso,et al.  Levodopa‐induced dyskinesias in Parkinson's disease: Clinical and pharmacological classification , 1992, Movement disorders : official journal of the Movement Disorder Society.

[95]  Hironobu Tokuno,et al.  Direct projections from the deep layers of the superior colliculus to the subthalamic nucleus in the rat , 1994, Brain Research.

[96]  J C Rothwell,et al.  Voluntary stimulus‐sensitive jerks and jumps mimicking myoclonus or pathological startle syndromes , 1992, Movement disorders : official journal of the Movement Disorder Society.

[97]  A J Lees,et al.  Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson’s disease , 1998, Journal of neurology, neurosurgery, and psychiatry.

[98]  P. LeWitt.  Conjugate eye deviations as dyskinesias induced by levodopa in Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.

[99]  G. Deuschl,et al.  Symptomatic and essential rhythmic palatal myoclonus. , 1990, Brain : a journal of neurology.

[100]  M. Hallett,et al.  The pathophysiology of primary dystonia. , 1998, Brain : a journal of neurology.

[101]  A. Benabid,et al.  Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 1998, The New England journal of medicine.

[102]  C. Marsden,et al.  The anatomical basis of symptomatic hemidystonia. , 1985, Brain : a journal of neurology.

[103]  R. Kostrzewa,et al.  Dopamine receptor supersensitivity , 1995, Neuroscience & Biobehavioral Reviews.

[104]  G. D. Lyons,et al.  The otological aspects of palatal myoclonus , 1976, The Laryngoscope.

[105]  U. Ziemann,et al.  Intracortical inhibition and facilitation in the conventional paired TMS paradigm. , 1999, Electroencephalography and clinical neurophysiology. Supplement.

[106]  I. Sando,et al.  Three-Dimensional Reconstruction and Measurement Study of Human Eustachian Tube Structures: A Hypothesis of Eustachian Tube Function , 1998, The Annals of otology, rhinology, and laryngology.

[107]  A. Hughes,et al.  Subcutaneous apomorphine in parkinson's disease: Response to chronic administration for up to five years , 1993, Movement disorders : official journal of the Movement Disorder Society.

[108]  H. Zeiger,et al.  Appendicular tremor as a late complication of intracerebral hemorrhage. , 1986, Surgical neurology.

[109]  C. Marsden,et al.  Control of on/off phenomenon by continuous intravenous infusion of levodopa , 1984, Neurology.

[110]  D. Denny-Brown.  Quelques aspects physiologiques des myoclonies. , 1968 .

[111]  A. Parent,et al.  The current model of basal ganglia organization under scrutiny , 1998, Movement disorders : official journal of the Movement Disorder Society.

[112]  P. Odin,et al.  Subcutaneous apomorphine in late stage Parkinson’s disease: a long term follow up , 1998, Journal of neurology, neurosurgery, and psychiatry.

[113]  Lee Lv,et al.  Torsion dystonia in Panay, Philippines. , 1976, Advances in neurology.

[114]  W. Poewe,et al.  Continuous subcutaneous apomorphine infusions for fluctuating Parkinson's disease. Long-term follow-up in 18 patients. , 1993, Advances in neurology.

[115]  L. Metman,et al.  Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease , 1998, Neurology.

[116]  M. Simonetta,et al.  Abnormal ocular movements in Parkinson's disease. Evidence for involvement of dopaminergic systems. , 1989, Brain : a journal of neurology.

[117]  J. Jankovic,et al.  Outcome after stereotactic thalamotomy for dystonia and hemiballismus. , 1995, Neurosurgery.

[118]  J. Hildebrand,et al.  Audiogenic startle reflex in acute hemiplegia , 1997, Neurology.

[119]  R. Deitch.  Commentary from Westminster , 1981, The Lancet.

[120]  E. Dietrichs,et al.  Bulbar myoclonus without palatal myoclonus. A hypothesis on pathophysiology , 1999, European journal of neurology.

[121]  M. B. Bender,et al.  Myoclonus of muscles of the eye, face, and throat. , 1952, A.M.A. archives of neurology and psychiatry.

[122]  David A. Hopkins,et al.  Substantia nigra projections to the reticular formation, superior colliculus and central gray in the rat, cat and monkey , 1976, Neuroscience Letters.

[123]  H. Vinters,et al.  Neuropathology of lubag (x‐linked dystonia parkinsonism) , 1993, Movement disorders : official journal of the Movement Disorder Society.

[124]  A. Doble.  The role of excitotoxicity in neurodegenerative disease: implications for therapy. , 1999 .

[125]  W. A. Hunt.  Studies of the Startle Pattern: II. Bodily Pattern , 1936 .

[126]  R. Kakigi,et al.  Somatosensory and acoustic brain stem reflex myoclonus. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[127]  A. Lees,et al.  SUBCUTANEOUS INFUSION OF APOMORPHINE AND LISURIDE IN THE TREATMENT OF PARKINSONIAN ON-OFF FLUCTUATIONS , 1987, The Lancet.

[128]  M. Hallett,et al.  Physiological abnormalities in hereditary hyperekplexia , 1992, Annals of neurology.

[129]  Jong S. Kim,et al.  Delayed onset mixed involuntary movements after thalamic stroke: clinical, radiological and pathophysiological findings. , 2001, Brain : a journal of neurology.

[130]  A. Lees,et al.  Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes , 1990, The Lancet.

[131]  A. Benabid,et al.  Subcutaneous apomorphine in Parkinson's disease. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[132]  N. J. Coker,et al.  Velo‐pharyngo‐laryngeal myoclonus: Evaluation of objective tinnitus and extrathoracic airway obstruction , 1984, The Laryngoscope.

[133]  U. Seitz,et al.  [3 H]-Monoamine Uptake Inhibition Properties of Kava Pyrones , 1997, Planta medica.

[134]  A. Scheibel,et al.  The organization of the nucleus reticularis thalami: a Golgi study. , 1966, Brain research.

[135]  M. Hallett,et al.  Audiogenic startle reflex of man and its relationship to startle syndromes. A review. , 1986, Brain : a journal of neurology.

[136]  G. Gessa,et al.  THERAPEUTIC EFFICACY OF APOMORPHINE COMBINED WITH AN EXTRACEREBRAL INHIBITOR OF DOPAMINE RECEPTORS IN PARKINSON'S DISEASE , 1979, The Lancet.

[137]  M Swash,et al.  Progressive encephalomyelitis with rigidity. , 1976, Brain : a journal of neurology.

[138]  P J Toghill,et al.  Spinal internuncial neurones in progressive encephalomyelitis with rigidity. , 1979, Journal of neurology, neurosurgery, and psychiatry.

[139]  M. Velasco,et al.  Neglect induced by thalamotomy in humans: a quantitative appraisal of the sensory and motor deficits. , 1986, Neurosurgery.

[140]  J. Jankovic,et al.  Hemidystonia: a report of 22 patients and a review of the literature. , 1985, Journal of neurology, neurosurgery, and psychiatry.

[141]  T. Ishikawa,et al.  The Metabolic Topography of Parkinsonism , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[142]  C D Marsden,et al.  Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy , 1990, Annals of neurology.

[143]  M. S. Lee,et al.  Movement disorders following lesions of the thalamus or subthalamic region , 1994, Movement disorders : official journal of the Movement Disorder Society.

[144]  T. Engber,et al.  Reversal of levodopa-induced motor fluctuations in experimental parkinsonism by NMDA receptor blockade , 1995, Brain Research.

[145]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[146]  R. Mayeux,et al.  Tics in a patient with Parkinson's disease , 1986, Movement disorders : official journal of the Movement Disorder Society.

[147]  J. Penney,et al.  The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.

[148]  G. Schaltenbrand,et al.  Atlas for Stereotaxy of the Human Brain , 1977 .

[149]  Y. Agid,et al.  Levodopa‐induced dyskinesias in Parkinson's disease phenomenology and pathophysiology , 1994, Movement disorders : official journal of the Movement Disorder Society.

[150]  O. Sacks,et al.  L-dopa and oculogyric crises. , 1970, Lancet.

[151]  A. Lees,et al.  The motor response to sequential apomorphine in parkinsonian fluctuations. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[152]  A. Antonini,et al.  Preoperative indicators of clinical outcome following stereotaxic pallidotomy , 1997, Neurology.

[153]  W. A. Hunt,et al.  Studies of the Startle Pattern: VI. Temporal Relations , 1937 .

[154]  A. Eisen,et al.  DOUBLE-BLIND STUDY OF BOTULINUM TOXIN IN SPASMODIC TORTICOLLIS , 1986, The Lancet.

[155]  J. Obeso,et al.  APOMORPHINE INFUSION FOR MOTOR FLUCTUATIONS IN PARKINSON'S DISEASE , 1987, The Lancet.

[156]  R. Benecke,et al.  Inhibitory actions of motor cortex following unilateral brain lesions as studied by magnetic brain stimulation , 2004, Experimental Brain Research.

[157]  A. Ferbert,et al.  Tremor due to stroke , 1993, Movement disorders : official journal of the Movement Disorder Society.